Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis

Autor: Ellen Li, Breana Channer, Anupama Chawla, Joseph F. LaComb, Shanawaj Khair, Farah Monzur, Jiyhe Park, Jonathan M. Buscaglia, Juan Carlos Bucobo, Michael Mintz, Suman Grewal, Charlie E Robertson, Daniel N. Frank, Jie Yang, Ramona Rajapakse
Rok vydání: 2018
Předmět:
0301 basic medicine
genetic structures
lcsh:Medicine
Pathology and Laboratory Medicine
Polymerase Chain Reaction
Biochemistry
Gastroenterology
Inflammatory bowel disease
Feces
Recurrence
Medicine and Health Sciences
Longitudinal Studies
Prospective Studies
lcsh:Science
Multidisciplinary
biology
Organic Compounds
Microbiota
Genomics
Fecal Microbiota Transplantation
Clostridium difficile
Colitis
Ulcerative colitis
Bacterial Pathogens
Nucleic acids
Chemistry
Treatment Outcome
Ribosomal RNA
Medical Microbiology
Physical Sciences
Steroids
Pathogens
Research Article
Cell biology
medicine.medical_specialty
Cellular structures and organelles
Clostridium Difficile
Firmicutes
Surgical and Invasive Medical Procedures
Gastroenterology and Hepatology
Microbial Genomics
Microbiology
03 medical and health sciences
Internal medicine
Genetics
medicine
Humans
Ulcerative Colitis
Microbiome
Non-coding RNA
Microbial Pathogens
Clostridium
Bacteria
Clostridioides difficile
business.industry
lcsh:R
Inflammatory Bowel Disease
Gut Bacteria
Organic Chemistry
Lachnospiraceae
Organisms
Chemical Compounds
Biology and Life Sciences
Endoscopy
Fusobacteria
medicine.disease
biology.organism_classification
030104 developmental biology
Clostridium Infections
RNA
lcsh:Q
Colitis
Ulcerative

business
Ribosomes
Zdroj: PLoS ONE
PLoS ONE, Vol 13, Iss 1, p e0190997 (2018)
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0190997
Popis: Background Studies of colonoscopic fecal microbiota transplant (FMT) in patients with recurrent CDI, indicate that this is a very effective treatment for preventing further relapses. In order to provide this service at Stony Brook University Hospital, we initiated an open-label prospective study of single colonoscopic FMT among patients with ≥ 2 recurrences of CDI, with the intention of monitoring microbial composition in the recipient before and after FMT, as compared with their respective donor. We also initiated a concurrent open label prospective trial of single colonoscopic FMT of patients with ulcerative colitis (UC) not responsive to therapy, after obtaining an IND permit (IND 15642). To characterize how FMT alters the fecal microbiota in patients with recurrent Clostridia difficile infections (CDI) and/or UC, we report the results of a pilot microbiome analysis of 11 recipients with a history of 2 or more recurrences of C. difficile infections without inflammatory bowel disease (CDI-only), 3 UC recipients with recurrent C. difficile infections (CDI + UC), and 5 UC recipients without a history of C. difficile infections (UC-only). Method V3V4 Illumina 16S ribosomal RNA (rRNA) gene sequencing was performed on the pre-FMT, 1-week post-FMT, and 3-months post-FMT recipient fecal samples along with those collected from the healthy donors. Fitted linear mixed models were used to examine the effects of Group (CDI-only, CDI + UC, UC-only), timing of FMT (Donor, pre-FMT, 1-week post-FMT, 3-months post-FMT) and first order Group*FMT interactions on the diversity and composition of fecal microbiota. Pairwise comparisons were then carried out on the recipient vs. donor and between the pre-FMT, 1-week post-FMT, and 3-months post-FMT recipient samples within each group. Results Significant effects of FMT on overall microbiota composition (e.g., beta diversity) were observed for the CDI-only and CDI + UC groups. Marked decreases in the relative abundances of the strictly anaerobic Bacteroidetes phylum, and two Firmicutes sub-phyla associated with butyrate production (Ruminococcaceae and Lachnospiraceae) were observed between the CDI-only and CDI + UC recipient groups. There were corresponding increases in the microaerophilic Proteobacteria phylum and the Firmicutes/Bacilli group in the CDI-only and CDI + UC recipient groups. At a more granular level, significant effects of FMT were observed for 81 genus-level operational taxonomic units (OTUs) in at least one of the three recipient groups (p
Databáze: OpenAIRE